Sona Nanotech Inc

Sona Nanotech, a nanotechnology Life Sciences company, is developing Targeted Hyperthermia TherapyTM, a photothermal cancer therapy, which uses therapeutic heat to treat solid cancer tumors. The heat is delivered to tumors by infrared light that is absorbed by Sonas gold nanorods in the tumor and re-emitted as heat. Therapeutic heat (41-48C) stimulates the immune system, shrinks tumors, inactivates cancer stem cells, and increases tumor perfusion thus enabling drugs to reach all tumor compartments more effectively. The size, shape, and surface chemistry of the gold nanorods target the leaky vasculature of solid tumors, and the selective thermal sensitivity of tumor tissue...

Ctab free gold nanorod production,gold nanoparticle development,gold nanorods for bio-medical applications,gold nanorods for cancer research,gold nanorods for drug delivery,gold nanorods for cell imaging,poc diagnostic applications,gold nanorods for lateral flow assays,medical,environment,health,pharmaceuticals,biomedical,military,diagnostic,science,technology,healthcare,research,lateral flow assay,and rapid antigen testing

Sona nanotech inc operates in the Nanotechnology research industry.

Sona nanotech inc's revenue is < 1m

Sona nanotech inc has 11 - 50 employees.